Cellectar Biosciences (NASDAQ:CLRB) Downgraded by Zacks Investment Research to Hold

Cellectar Biosciences} stock has undergone multiple analysts rating changes in the recent past.  Cellectar Biosciences Downgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Cellectar Biosciences (NASDAQ:CLRB) Downgraded by Zacks Investment Research to Hold

Cellectar Biosciences (CLRB) Upgraded by Zacks Investment Research to Buy

Cellectar Biosciences} stock has undergone multiple analysts rating changes in the recent past.  Cellectar Biosciences Upgraded by Zacks Investment Research on 10-11-21. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

View More Cellectar Biosciences (CLRB) Upgraded by Zacks Investment Research to Buy